Author/Authors :
Sarıkabadayı, Yusuf Ünal Zekai Tahir Burak Maternity Teaching Hospital - Neonatal Unit, Turkey , Erdeve, Ömer Zekai Tahir Burak Maternity Teaching Hospital - Neonatal Unit, Turkey , Oğuz, Şerife Suna Zekai Tahir Burak Maternity Teaching Hospital - Neonatal Unit, Turkey , Altuğ, Nahide Zekai Tahir Burak Maternity Teaching Hospital - Clinic of Pediatric Cardiology, Turkey , Dilmen, Uğur Zekai Tahir Burak Maternity Teaching Hospital - Neonatal Unit, Turkey
Abstract :
Infants with chronic lung disease are at greater risk for pulmonary compromise in childhood. Hydrocortisone has been studied in the treatment of chronic lung disease. A preterm infant, with a gestational age of 26 weeks, was admitted to the neonatal intensive care unit. On the 28th postnatal day, the patient still had oxygen requirement (FiO2: 0.40) and hydrocortisone treatment was given for seven days. After the treatment the echocardiography revealed a remarkable thickening of the left ventricle and interventricular septum. The case reported here is the first preterm infant with cardiac hypertrophy due to hydrocortisone administration for treatment of chronic lung disease.
